Shares of BioDelivery Sciences International soared for a second straight day Friday, the day after the company announced positive news about its lead experimental drug.
Claes Wahlestedt, who heads Scripps Florida’s efforts to develop drugs for diseases of the central nervous system, has launched new company with business consultant and longtime friend Joe Collard.